DK1399144T3 - Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser - Google Patents
Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelserInfo
- Publication number
- DK1399144T3 DK1399144T3 DK02759750T DK02759750T DK1399144T3 DK 1399144 T3 DK1399144 T3 DK 1399144T3 DK 02759750 T DK02759750 T DK 02759750T DK 02759750 T DK02759750 T DK 02759750T DK 1399144 T3 DK1399144 T3 DK 1399144T3
- Authority
- DK
- Denmark
- Prior art keywords
- group
- anxiety disorders
- phenyl
- alkyl
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27168901P | 2001-02-27 | 2001-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1399144T3 true DK1399144T3 (da) | 2006-07-24 |
Family
ID=23036639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02759750T DK1399144T3 (da) | 2001-02-27 | 2002-02-21 | Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US7078436B2 (da) |
| EP (1) | EP1399144B1 (da) |
| JP (1) | JP2004523554A (da) |
| KR (1) | KR20030078947A (da) |
| CN (1) | CN1503665A (da) |
| AT (1) | ATE324107T1 (da) |
| AU (1) | AU2002306567B2 (da) |
| BR (1) | BR0207830A (da) |
| CA (1) | CA2439286A1 (da) |
| CY (1) | CY1107468T1 (da) |
| CZ (1) | CZ20032311A3 (da) |
| DE (1) | DE60210960T2 (da) |
| DK (1) | DK1399144T3 (da) |
| ES (1) | ES2262826T3 (da) |
| HK (1) | HK1062270A1 (da) |
| HU (1) | HUP0303262A2 (da) |
| IL (1) | IL157594A0 (da) |
| MX (1) | MXPA03007720A (da) |
| MY (1) | MY136391A (da) |
| NO (1) | NO20033800L (da) |
| NZ (1) | NZ546549A (da) |
| PL (1) | PL364639A1 (da) |
| PT (1) | PT1399144E (da) |
| RS (1) | RS50505B (da) |
| RU (1) | RU2292881C2 (da) |
| WO (1) | WO2002067923A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS50505B (sr) * | 2001-02-27 | 2010-03-02 | Ortho-Mcneil Pharmaceutical Inc. | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju anksioznih poremećaja |
| CA2595599A1 (en) * | 2005-01-20 | 2006-07-27 | Janssen Pharmaceutica N.V. | Methods for qt interval control |
| AU2006254899B2 (en) | 2005-06-08 | 2011-11-24 | Sk Biopharmaceuticals Co., Ltd. | Treatment of sleep-wake disorders |
| CA2667510A1 (en) * | 2006-10-27 | 2008-06-12 | Janssen Pharmaceutica N.V. | Methods for treating disruptive behavior disorders |
| US8263652B2 (en) | 2007-10-31 | 2012-09-11 | Sk Biopharmaceuticals Co., Ltd. | Stabilized pediatric suspension of carisbamate |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| KR102014615B1 (ko) * | 2013-03-12 | 2019-08-27 | (주)바이오팜솔루션즈 | 페닐카바메이트 화합물 및 이를 포함하는 신경보호용 조성물 |
| CN109939092B (zh) | 2013-03-12 | 2022-03-22 | 比皮艾思药物研发有限公司 | 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物 |
| EP3423433A4 (en) * | 2016-02-29 | 2019-12-25 | Bio-Pharm Solutions Co., Ltd. | SULFAMATE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| KR20200016889A (ko) | 2017-06-02 | 2020-02-17 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 과다 졸림증을 치료하기 위한 방법 및 조성물 |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3278380A (en) * | 1962-02-06 | 1966-10-11 | Armour Pharma | Methods of calming employing diphenyl hydroxy carbamate compounds |
| US3248418A (en) | 1962-06-26 | 1966-04-26 | Charles D Bossinger | 2-hydroxy-2-phenyl alkyl carbamates |
| US3265728A (en) | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| US5698588A (en) | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| MXPA03007722A (es) | 2001-02-27 | 2004-11-12 | Johnson & Johnson | Compuestos de carbamato para usar en la prevencion o tratamiento de trastornos sicoticos. |
| DK1408953T3 (da) | 2001-02-27 | 2006-08-21 | Ortho Mcneil Pharm Inc | Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom |
| RS50505B (sr) * | 2001-02-27 | 2010-03-02 | Ortho-Mcneil Pharmaceutical Inc. | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju anksioznih poremećaja |
-
2002
- 2002-02-21 RS YUP-679/03A patent/RS50505B/sr unknown
- 2002-02-21 CA CA002439286A patent/CA2439286A1/en not_active Abandoned
- 2002-02-21 CN CNA028087143A patent/CN1503665A/zh active Pending
- 2002-02-21 BR BR0207830-9A patent/BR0207830A/pt not_active IP Right Cessation
- 2002-02-21 WO PCT/US2002/005423 patent/WO2002067923A1/en active IP Right Grant
- 2002-02-21 CZ CZ20032311A patent/CZ20032311A3/cs unknown
- 2002-02-21 AT AT02759750T patent/ATE324107T1/de active
- 2002-02-21 PL PL02364639A patent/PL364639A1/xx not_active Application Discontinuation
- 2002-02-21 NZ NZ546549A patent/NZ546549A/en not_active IP Right Cessation
- 2002-02-21 KR KR10-2003-7011293A patent/KR20030078947A/ko not_active Application Discontinuation
- 2002-02-21 RU RU2003128986/14A patent/RU2292881C2/ru not_active IP Right Cessation
- 2002-02-21 ES ES02759750T patent/ES2262826T3/es not_active Expired - Lifetime
- 2002-02-21 JP JP2002567290A patent/JP2004523554A/ja active Pending
- 2002-02-21 HU HU0303262A patent/HUP0303262A2/hu unknown
- 2002-02-21 PT PT02759750T patent/PT1399144E/pt unknown
- 2002-02-21 DE DE60210960T patent/DE60210960T2/de not_active Expired - Lifetime
- 2002-02-21 EP EP02759750A patent/EP1399144B1/en not_active Expired - Lifetime
- 2002-02-21 MX MXPA03007720A patent/MXPA03007720A/es active IP Right Grant
- 2002-02-21 DK DK02759750T patent/DK1399144T3/da active
- 2002-02-21 US US10/081,713 patent/US7078436B2/en not_active Expired - Fee Related
- 2002-02-21 AU AU2002306567A patent/AU2002306567B2/en not_active Ceased
- 2002-02-21 IL IL15759402A patent/IL157594A0/xx unknown
- 2002-02-27 MY MYPI20020693A patent/MY136391A/en unknown
-
2003
- 2003-08-26 NO NO20033800A patent/NO20033800L/no not_active Application Discontinuation
-
2004
- 2004-07-19 HK HK04105268A patent/HK1062270A1/xx not_active IP Right Cessation
-
2005
- 2005-08-01 US US11/194,251 patent/US20050267203A1/en not_active Abandoned
-
2006
- 2006-06-21 CY CY20061100843T patent/CY1107468T1/el unknown
-
2009
- 2009-06-01 US US12/475,815 patent/US20090234003A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO20033800D0 (no) | 2003-08-26 |
| CZ20032311A3 (cs) | 2005-02-16 |
| DE60210960T2 (de) | 2006-11-16 |
| BR0207830A (pt) | 2004-06-22 |
| IL157594A0 (en) | 2004-03-28 |
| YU67903A (sh) | 2006-08-17 |
| NO20033800L (no) | 2003-09-26 |
| US7078436B2 (en) | 2006-07-18 |
| CY1107468T1 (el) | 2012-12-19 |
| RS50505B (sr) | 2010-03-02 |
| PL364639A1 (en) | 2004-12-13 |
| MY136391A (en) | 2008-09-30 |
| US20050267203A1 (en) | 2005-12-01 |
| AU2002306567B2 (en) | 2006-08-17 |
| US20020143053A1 (en) | 2002-10-03 |
| PT1399144E (pt) | 2006-07-31 |
| RU2003128986A (ru) | 2005-03-20 |
| EP1399144B1 (en) | 2006-04-26 |
| KR20030078947A (ko) | 2003-10-08 |
| RU2292881C2 (ru) | 2007-02-10 |
| NZ546549A (en) | 2007-11-30 |
| EP1399144A1 (en) | 2004-03-24 |
| CA2439286A1 (en) | 2002-09-06 |
| JP2004523554A (ja) | 2004-08-05 |
| WO2002067923A1 (en) | 2002-09-06 |
| MXPA03007720A (es) | 2004-11-12 |
| ATE324107T1 (de) | 2006-05-15 |
| ES2262826T3 (es) | 2006-12-01 |
| DE60210960D1 (de) | 2006-06-01 |
| HK1062270A1 (en) | 2004-10-29 |
| HUP0303262A2 (hu) | 2004-01-28 |
| CN1503665A (zh) | 2004-06-09 |
| US20090234003A1 (en) | 2009-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY138156A (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders | |
| MY157373A (en) | Carbamate compounds for use in preventing or treating movement disorders | |
| DK1408953T3 (da) | Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom | |
| DK1368021T3 (da) | Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom | |
| DK1399144T3 (da) | Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser | |
| RS67603A (en) | Carbamate compounds for use in the treatment of pain | |
| RS67503A (en) | Carbamate compounds for use in preventing of treating psychotic disorders | |
| DK1305082T3 (da) | Carbamatforbindelser til anvendelse til forebyggelse eller behandling af neuropatisk smerte og klynge- eller migrænehovedpine-associeret smerte | |
| DK1408954T3 (da) | Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neuropatisk smerte | |
| MY136733A (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| MY136347A (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |